Related Experiment Video

Updated: May 28, 2026

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents
07:26

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents

Published on: July 14, 2021

Angiotensin receptor blockers are associated with a lower remodelling score of stenotic aortic valves

Nancy Côté1, Christian Couture, Philippe Pibarot

  • 1Department of Surgery, Laboratoire d'Études Moléculaires des Valvulopathies, Institut Universitaire de Cardiologie et de Pneumologie de Québec/Research Center, Laval University, QC, Canada.

European Journal of Clinical Investigation
|October 13, 2011
PubMed
Abstract

Insights

Angiotensin II receptor blockers (ARBs) were linked to reduced aortic valve weight and tissue remodelling in patients with aortic stenosis (AS). Further research is needed to explore ARBs as a potential therapy for AS progression.

Area of Science:

  • Cardiology
  • Pharmacology
  • Pathology

Background:

  • Inhibitors of the renin-angiotensin system (RAS) may slow valvular calcification in aortic stenosis (AS).
  • Understanding the impact of RAS inhibitors on aortic valve remodelling is crucial for AS management.

Purpose of the Study:

  • To assess the relationship between aortic valve weight, tissue remodelling score, and calcium content in AS patients.
  • To determine the effect of angiotensin II receptor type I blockers (ARBs) and angiotensin-converting enzyme (ACE) inhibitors on these variables.

Main Methods:

  • Collected aortic valves and plasma from 208 AS patients undergoing valve replacement.
  • Weighed valves, assessed tissue remodelling using a 1-4 scoring system, and measured calcium content.
  • Analyzed the correlation between valve characteristics and medication use, including ARBs.

Main Results:

  • Higher valve weight and remodelling scores were observed in men and patients with bicuspid valves.
  • Both valve weight and remodelling score correlated positively with aortic valve calcium content.
  • Patients on ARBs exhibited significantly lower aortic valve weights and remodelling scores compared to those not on ARBs.

Conclusions:

  • ARBs are associated with reduced aortic valve weight and less tissue remodelling in AS.
  • These findings suggest ARBs may have a role in mitigating AS progression.
  • Further investigation is warranted to establish ARBs as a therapeutic strategy for aortic stenosis.

More Related Videos

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

Related Concept Videos

Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...